Iatrogenic cerebral amyloid angiopathy: an emerging clinical phenomenon
G Banerjee, K Samra, ME Adams… - Journal of Neurology …, 2022 - jnnp.bmj.com
In the last 6 years, following the first pathological description of presumed amyloid-beta (Aβ)
transmission in humans (in 2015) and subsequent experimental confirmation (in 2018) …
transmission in humans (in 2015) and subsequent experimental confirmation (in 2018) …
[HTML][HTML] Iatrogenic cerebral amyloid angiopathy: an emerging clinical phenomenon
G Banerjee, K Samra, ME Adams… - Journal of Neurology …, 2022 - jnnp.bmj.com
In the last 6 years, following the first pathological description of presumed amyloid-beta (Aβ)
transmission in humans (in 2015) and subsequent experimental confirmation (in 2018) …
transmission in humans (in 2015) and subsequent experimental confirmation (in 2018) …
Iatrogenic cerebral amyloid angiopathy: an emerging clinical phenomenon
G Banerjee, K Samra, ME Adams… - Journal of …, 2022 - search.proquest.com
In the last 6 years, following the first pathological description of presumed amyloid-beta (Aβ)
transmission in humans (in 2015) and subsequent experimental confirmation (in 2018) …
transmission in humans (in 2015) and subsequent experimental confirmation (in 2018) …
Iatrogenic cerebral amyloid angiopathy: an emerging clinical phenomenon
G Banerjee, K Samra, ME Adams… - Journal of Neurology …, 2022 - discovery.ucl.ac.uk
In the last 6 years, following the first pathological description of presumed amyloid-beta (Aβ)
transmission in humans (in 2015) and subsequent experimental confirmation (in 2018) …
transmission in humans (in 2015) and subsequent experimental confirmation (in 2018) …
Iatrogenic cerebral amyloid angiopathy: an emerging clinical phenomenon
G Banerjee, K Samra, ME Adams… - Journal of neurology … - pubmed.ncbi.nlm.nih.gov
In the last 6 years, following the first pathological description of presumed amyloid-beta (Aβ)
transmission in humans (in 2015) and subsequent experimental confirmation (in 2018) …
transmission in humans (in 2015) and subsequent experimental confirmation (in 2018) …
Iatrogenic cerebral amyloid angiopathy: an emerging clinical phenomenon.
G Banerjee, K Samra, ME Adams… - Journal of Neurology …, 2022 - europepmc.org
In the last 6 years, following the first pathological description of presumed amyloid-beta (Aβ)
transmission in humans (in 2015) and subsequent experimental confirmation (in 2018) …
transmission in humans (in 2015) and subsequent experimental confirmation (in 2018) …
Iatrogenic cerebral amyloid angiopathy: an emerging clinical phenomenon
G Banerjee, K Samra, ME Adams… - Journal of …, 2022 - research.manchester.ac.uk
In the last 6 years, following the first pathological description of presumed amyloid-beta (Aβ)
transmission in humans (in 2015) and subsequent experimental confirmation (in 2018) …
transmission in humans (in 2015) and subsequent experimental confirmation (in 2018) …
[PDF][PDF] IATROGENIC CEREBRAL AMYLOID ANGIOPATHY: AN EMERGING CLINICAL PHENOMENON
JM Schott, DJWF PhD10 - researchgate.net
In the last six years following the first pathological description of presumed amyloid-beta
(Aβ) transmission in humans (in 2015) and subsequent experimental confirmation (in 2018) …
(Aβ) transmission in humans (in 2015) and subsequent experimental confirmation (in 2018) …
Iatrogenic cerebral amyloid angiopathy: an emerging clinical phenomenon
G Banerjee, K Samra, ME Adams… - Journal of …, 2022 - research.manchester.ac.uk
In the last 6 years, following the first pathological description of presumed amyloid-beta (Aβ)
transmission in humans (in 2015) and subsequent experimental confirmation (in 2018) …
transmission in humans (in 2015) and subsequent experimental confirmation (in 2018) …